NCT04951570

Clinical Diagnosis and Treatment of Intracerebral Hemorrhage Based on Artificial Intelligence

Clinical Diagnosis and Treatment of Intracerebral Hemorrhage Based on Artificial

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,374 (actual)
• Sponsor: Beijing Tiantan Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

The purpose of this study is to test the reliability and validity of an artificial intelligence system and a related 5-score scale to predict hematoma expansion, and conduct a study cohort of intracerebral hemorrhage to screen out imaging and biological markers that could predict hematoma expansion in real-world.

Detailed description

This is a investigator-initiated, multi-center, prospective, registered cohort study. The study is intended to enroll 4000 patients with intracerebral hemorrhage from 50 hospital in China. Clinical and imaging data, as well as the results of laboratory examination will be collected to test the reliability and validity of an artificial intelligence system and a related 5-score scale to predict hematoma expansion, and conduct a study cohort of intracerebral hemorrhage to screen out imaging and biological markers that could predict hematoma expansion in real-world.

Conditions

• Intracerebral Hemorrhage

Timeline

• Start date: 2021-06-23
• Primary completion: 2023-02-02
• Completion: 2023-02-02
• First posted: 2021-07-07
• Last updated: 2023-02-28

Locations

1 site across 1 country: China